Antibiotic Treatment for Enterococcus faecium Infections
For Enterococcus faecium infections, linezolid is the most effective treatment option for vancomycin-resistant strains, while ampicillin remains the drug of choice for ampicillin-susceptible strains. 1, 2
First-Line Treatment Algorithm
Step 1: Determine Susceptibility Pattern
- For ampicillin-susceptible E. faecium: Use ampicillin as first-line therapy 1
- For vancomycin-susceptible but ampicillin-resistant E. faecium: Use vancomycin 2
- For vancomycin-resistant E. faecium (VRE): Use linezolid 600 mg IV/PO every 12 hours 2, 3
Step 2: Alternative Options for VRE
- Daptomycin 8-12 mg/kg/day IV is recommended as an alternative for VRE bacteremia 2, 4
- Quinupristin-dalfopristin (Synercid) inhibits growth only in E. faecium (not E. faecalis) 2, 5
- Tigecycline 100 mg IV loading dose followed by 50 mg IV every 12 hours for intra-abdominal infections 2
Clinical Considerations
Antimicrobial Resistance Patterns
- E. faecium is more likely to be resistant to multiple antibiotics compared to E. faecalis 1, 6
- Five phenotypes of vancomycin resistance (vanA through E) exist in enterococci, with vanA and vanB genes found primarily in E. faecium 2
- Vancomycin-resistant E. faecium is often multidrug-resistant, creating significant treatment challenges 2, 7
Combination Therapy for Severe Infections
- For severe VRE infections, consider combination therapy with daptomycin plus ampicillin or ceftaroline for potential synergistic effects 1, 8
- Double β-lactam combinations (imipenem and ampicillin or cephalosporins plus ampicillin) have shown synergistic bactericidal activity against some E. faecalis strains 2
Special Situations
Urinary Tract Infections
- For uncomplicated VRE urinary tract infections, consider:
Endocarditis
- For endocarditis caused by vancomycin-resistant E. faecium, linezolid therapy resulted in cure of 77% of cases 2
- Daptomycin at higher doses (10-12 mg/kg/day) may be more effective for serious infections like endocarditis 1, 4
Common Pitfalls and Monitoring
- Linezolid resistance can emerge during therapy, particularly with prolonged use (>14 days) 9, 10
- Monitor for bone marrow suppression and neuropathy with prolonged linezolid use 1
- Enterococci are intrinsically resistant to cephalosporins when used as monotherapy 1
- Daptomycin monotherapy may lead to treatment failure in severe infections; consider combination therapy for better outcomes 1, 8
- The FDA has approved linezolid specifically for the treatment of vancomycin-resistant Enterococcus faecium infections, including cases with concurrent bacteremia 3